+467.0%
MRNA vs NSC
+19.9%
+447.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NSC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -0.9% | +6.3% | +6.1% |
| 7D | -1.1% | -2.8% | +1.7% | +1.2% |
| 30D | +126.1% | -4.5% | +130.6% | +138.1% |
| 3M | +190.0% | +3.5% | +186.5% | +199.8% |
| 6M | +157.2% | +8.5% | +148.7% | +157.5% |
| YTD | +388.2% | +12.3% | +375.9% | +365.4% |
| 1Y | +467.0% | +18.9% | +448.1% | +404.3% |
| All | +467.0% | +19.9% | +447.2% | +404.3% |
Cumulative growth
Daily Returns
Daily percentage return beside NSC.
Daily Out/Under-Performance
Portfolio return minus NSC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NSC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NSC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling